Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Marignier

Showing results (1-10 of 215) with videos related to

Pageof 22
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 13, 2025
A breathtaking case of NMOSD: About pulmonary involvement in patients with AQP4-antibodiesRomain Marignier
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 25, 2022
It is imperative to reconsider the concept of seronegative NMOSDRomain Marignier
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 1, 2018
Unusual presentations of MOG antibody-associated central nervous system demyelination: Expanding the spectrumRomain Marignier
The Lancet. Neurology|February 15, 2020
Breaking boundaries between demyelinating disorders and autoimmune encephalitisRomain Marignier
La Revue Du Praticien|April 21, 2010
[Multiple sclerosis. What about treatment with monoclonal antibodies?]Romain Marignier, Christian Confavreux
Presse Medicale (Paris, France : 1983)|February 2, 2010
[Devic's neuromyelitis optica and related neurological disorders]Romain Marignier, Christian Confavreux
Nature Reviews. Neurology|April 22, 2015
Multiple sclerosis and pregnancy in the 'treatment era'Sandra Vukusic, Romain Marignier
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2025
Treatment discontinuation in MOGAD: A reassuring step forwardYael Hacohen, Romain Marignier
Continuum (Minneapolis, Minn.)|April 2, 2026
Neuromyelitis Optica Spectrum DisorderSara Mariotto, Romain Marignier
Neurology|October 1, 2024
Eculizumab in AQP4-IgG NMOSD: Efficacy in the Real World and Potential Warning of Meningococcal VaccinesRomain Marignier, Amy Kunchok
Pageof 22

Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 13, 2025
A breathtaking case of NMOSD: About pulmonary involvement in patients with AQP4-antibodiesRomain Marignier
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 25, 2022
It is imperative to reconsider the concept of seronegative NMOSDRomain Marignier
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 1, 2018
Unusual presentations of MOG antibody-associated central nervous system demyelination: Expanding the spectrumRomain Marignier
The Lancet. Neurology|February 15, 2020
Breaking boundaries between demyelinating disorders and autoimmune encephalitisRomain Marignier
La Revue Du Praticien|April 21, 2010
[Multiple sclerosis. What about treatment with monoclonal antibodies?]Romain Marignier, Christian Confavreux
Presse Medicale (Paris, France : 1983)|February 2, 2010
[Devic's neuromyelitis optica and related neurological disorders]Romain Marignier, Christian Confavreux
Nature Reviews. Neurology|April 22, 2015
Multiple sclerosis and pregnancy in the 'treatment era'Sandra Vukusic, Romain Marignier
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2025
Treatment discontinuation in MOGAD: A reassuring step forwardYael Hacohen, Romain Marignier
Continuum (Minneapolis, Minn.)|April 2, 2026
Neuromyelitis Optica Spectrum DisorderSara Mariotto, Romain Marignier
Neurology|October 1, 2024
Eculizumab in AQP4-IgG NMOSD: Efficacy in the Real World and Potential Warning of Meningococcal VaccinesRomain Marignier, Amy Kunchok
Pageof 22